Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of IVIG Versus PLEX in Myasthenic Crisis
NCT07532707Completed
- Sponsor
- Damascus University
- Start
- Sep 2022
- Primary completion
- Oct 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of intravenous immunoglobulin G in myasthenic crisis (MC) (2 arms), sponsored by Damascus University. Primary endpoint: Mean Change from Baseline in the Quantitative Myasthenia Gravis Score at Day 14. Started Sep 2022; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
myasthenic crisis (MC)
Beyond the preview
Go deeper on NCT07532707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07532707.